Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2017-01-03 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
第七届监事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from Jiangsu Sihuan Bio-Pharmaceutical Co., Ltd. regarding the resolution of the 17th meeting of the 7th Supervisory Board. It details the election proposal for the new Supervisory Board members, including candidate resumes and voting results. The content focuses on board/management changes, specifically the election and nomination of supervisory board members, which aligns with announcements about changes in company board or senior management. The document length is short (1813 characters) and contains no financial data or report content, so it is not an annual or interim report. It is not a voting result announcement since it pertains to supervisory board election proposals and candidate information rather than shareholder vote outcomes. Therefore, the classification best fits Board/Management Information (MANG).
2017-01-03 Chinese
独立董事提名人声明（六）
Board/Management Information Classification · 95% confidence The document is a public statement by a nominator regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and independence criteria of the nominee. There is no financial data, no report of financial results, no voting results, no management changes announcement, and no mention of any report publication. The content is focused on governance and compliance related to board nominations. This fits best under Board/Management Information (MANG) as it concerns the nomination of a board member.
2017-01-03 Chinese
独立董事候选人声明（廖述斌）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of Jiangsu Sihuan Bioengineering Co., Ltd., affirming compliance with various legal and regulatory requirements for independent directors. It includes statements about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no report of financial performance, no voting results, no management changes, no earnings information, and no mention of any report publication. The document is a formal declaration related to board/management information, specifically concerning the appointment or candidacy of an independent director. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is under 5,000 characters, but it is not an announcement of a report publication; it is a substantive declaration related to management.
2017-01-03 Chinese
独立董事提名人声明（四）
Board/Management Information Classification · 95% confidence The document is a public statement by a nominator regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with legal and regulatory requirements, and independence criteria of the nominee. There is no financial data, no report of financial results, no voting results, no management changes announcement, and no mention of any report publication or regulatory filing. The content is focused on board/management information specifically about the nomination of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report but a substantive statement about a board nomination.
2017-01-03 Chinese
2017年第一次临时董事会会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from Jiangsu Sihuan Bioengineering Co., Ltd. regarding the resolutions passed at the company's 2017 first extraordinary board meeting. It details the election of a new board of directors, including independent directors, and provides biographies of the director candidates. The document also mentions the upcoming shareholder meeting to approve the board election. There are no financial statements or detailed financial performance data. The content focuses on board/management changes and election procedures. The document length is 4094 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Board/Management Information (MANG).
2017-01-03 Chinese
独立董事提名人声明（三）
Board/Management Information Classification · 95% confidence The document is a public statement by a nominator regarding the nomination of an independent director candidate for the company's board. It includes detailed qualifications, compliance with legal and regulatory requirements, and declarations about the nominee's independence and suitability. There is no financial data, earnings information, or report publication mentioned. The content is focused on board/management changes, specifically the nomination of a new independent director. The document length is 3310 characters, which is relatively short and consistent with a nomination statement rather than a full report. Therefore, the document fits best under the category of Board/Management Information (MANG).
2017-01-03 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.